chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I was probably exposed on Tuesday, 07/19/2022 at work. I just started feeling sort of bad and woke up with a fever on 07/24/2022. I took an at home COVID-19 test which was positive. I ran a fever for around 2 days. I got my fever down, but I just felt really wiped out for 2 more days after that. Altogether, I missed 5 days of work. I stayed really well hydrated, I did not lose appetite or sense of taste or smell. I had a real sore throat for at least the whole 5 days. I also had a really stuffy head and nose for closer to 10 days. I emailed my doctor's office after testing positive for COVID-19 who advised that I just use over the counter medication to mitigate my symptoms until they improved.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. The patient's medical history was not reported. On 02-FEB-2015 the patient was received improperly stored VARIVAX (Merck) (lot # K007979, expiration date 03-JUN-2016, dose and route unknown). Concomitant medication was not reported. No adverse effects were reported. No product quality issue (PQC) was involved. This is one of several reports received from the same source. Additional information is not expected since the reporter don't wish us to contact.
Had vaccine at 2:00pm on 12/21/21, woke up 12/22/21 with right orbital edema. It is slightly painful  and red. I have been applying hot and cool compresses and taking Benadryl.
Vaccination site pain; Vaccination site warmth; Vaccination site erythema; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (rVaccination site erythema), the first episode of VACCINATION SITE PAIN (Vaccination site pain), VACCINATION SITE WARMTH (Vaccination site warmth) and the second episode of VACCINATION SITE PAIN (Vaccination site pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (rVaccination site erythema), the first episode of VACCINATION SITE PAIN (Vaccination site pain) and VACCINATION SITE WARMTH (Vaccination site warmth). On an unknown date, the patient experienced the second episode of VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, VACCINATION SITE ERYTHEMA (rVaccination site erythema), VACCINATION SITE WARMTH (Vaccination site warmth) and the last episode of VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
At approximately 1am, on Sept. 20th. I developed ringing in my left ear which I know to be Tinnitus. I also had a migraine and chills. The ringing is so bad I am not processing sound in my ear. I let my primary Doctor know during a check-in appointment I already had scheduled. He prescribed Prednisone 5mg for three days to see if it would help. It's been 24 hours and my hearing/tinnitus hasn't improved. I contracted an ENT office to schedule a hearing test but it will be a few weeks until they can give me the test.  I am not clear if this is permanent or will subside in time.
Pt states "this happens a lot", and is certain it is not the vaccine, but her bodies response.
Severe headache starting around 2 am that only got worse as the day went on and ending around 6 pm. When I woke up at 7 am I became very faint about 10 minutes after getting up and walking around; it sounded like I was underwater, I had tunnel vision, I could not speak coherently, and I was sweating. This subsided about 15 minutes after laying on the cold floor with a cold towel.  The faintness completely disappeared after an hour
30 Hours after the shot without any warning or ill effects, I suddenly collapsed from my chair at the dining room table.  Fell on the floor unconscious and ended up in the Emergency room with a broken nose ,concussion, and no memory of the episode.  Hospital did a CAT scan which did not show indication of a stroke but did verify concussion and broken nose.  Later saw personal physician and heart monitor was placed on my body, and echo cardiogram scheduled.  Echo cardiogram did not indicate any blockage.  Results from heart monitor not available at this time.  I am a perfectly healthy individual - walk 3-4 miles every day, swim, play golf, eat a keto diet and have never had an episode like this.  An hour before it oc   Apple watch 6 texted a message that read:  "are you okay or should we call 911".    I was perfectly fine and just thought the message was a fluke - replied I am fine.  An hour later the episode occured.  I am not used to taking vaccines - no flu shots, no shingles shots - only keep up my tetanus.  The only vaccine I have had recently was in 2009 - yellow fever shot so I could travel to.  I have never had a reaction like the one after the Moderna vaccine.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and genders. The reporter stated that, on an unspecified date, an unknown number of doses of LIQUID PEDVAXHIB (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported.   Follow up information has been received on 22-JUL-2014 from a receptionist. The reporter stated that there were two different lot numbers of LIQUID PEDVAXHIB that were included in the temperature excursion: Lot#J016188, expiration date:02-OCT-2016 and lot# J015437, expiration date: 09-OCT-2016.  The receptionist did not have any additional information to share.  Follow-up information has been received from the registered nurse who provided patients details. This report refers to a 14 months old child patient of unknown gender. On 12-JUN-2014 the patient was vaccinated with a dose of LIQUID PEDVAXHIB (dose and route not reported, lot # J015437, expiration date 09-OCT-2016) that was improperly stored. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected.
Information has been received from a physician concerning a 15 year old female with a cough and history of migraine who on 30-JUN-2008 was vaccinated with the first dose GARDASIL vaccine (yeast) (Lot number 660555/0279X). There was no concomitant medication. On 07-JUL-2008, seven day later, she was diagnosed with iritis. She was seen by an ophthalmologist and received an unnamed treatment. She was also scheduled to see a rheumatologist. She had a cough before receiving GARDASIL vaccine (yeast) and still had the cough. At the time for this reporting, the patient's iritis persisted. Additional information has been requested.  1/12/2009 MR received from 7/10/08-11/25/08 with DX:  Chronic anterior uveitis, both eyes, without uveitic complications.  Hx of migraine episodes.  Sinus disease. Chronic cough.  Elevated CRP and ESR. Proteinuria. Pt initially presented 7/10/08 with c/o 1 wk hx of intermittent blurred vision of the L eye and 3 week hx of cough. PE (+) for conjunctival injection with 2+ cells in anterior chamber.  Impression:  Acute Iritis OS of unknown etiology.  Early myopia. F/U 7/16/2008 now bilateral Iritis. Consult 8/19/08 with another ophth.  Referred for eval and mgmt of uveitis, both eyes due to little response to previous tx with topical steroid. ? TINU (Tubulo-interstitial nephritis and uveitis) being considered 2' to proteinuria.  2/2/09 MR received from rheumatology and nephrology consults.  Seen 7/16/08 with c/o blurry eyes, decreased vision, red eyes, recent chest pain and cough and congestion. PE (+) for mild scoliosis. DX:  Iritis.  Cough and congestion. Wegener's Granulomatosis. Increased Sed rate, (+) ANA. Mild scoliosis. Proteinuria. F/U visit Dx changed to Likely TINU-Tubulo-interstitial nephritis: mild uveitis and nephritis.  Hemangioma T4 spinal vertebra.  Sinusitis.  Seasonal allergies. Now c/o back pain-lower back and T12 to L1-4. Referred to nephrology for proteinuria. Uveitis slowly improving with steroid drops. Proteinuria resolved.
Information has been received from a health professional concerning a 5 year old patient who on 02/16/2001 was vaccinated with a dose of varicella virus vaccine live.  On 02/22/2005 the patient presented with about 20 lesions attributed to breakthrough varicella.  Unspecified medical attention was sought.  No treatment was needed.  There was no product quality complaint involved.  Additional information has been requested.  This is in follow-up to report (s) previously submitted on 5/16/2005.  Information has been received from a health professional concerning a 5 year old white male patient who on 16-FEB-2001 was vaccinated with a first dose of VARIVAX (Merck) (lot # 635449/1141K).  Concomitant vaccination that day included a second dose of PNU-IMUNE 23) (lot # 473-319).  On 22-FEB-2005 the patient presented with "about" 20 lesions attributed to breakthrough varicella.  Unspecified medical attention was sought.  No treatment was needed.  There was no product quality complaint involved.  Follow-up information from the health professional indicated that on 19-FEB-2005 the patient "had 20 lesions".  Subsequently the patient recovered.  Additional information is not expected.
Mom says that today 10/21/2005 at 6:00am. Noticed left arm was red, swollen and hot. Was evaluated by DR. Treatment Benadryl, Prelone, Cephalexin, Zyrtec PO. Per f/u with reporter, on 11/17/05 the doctor made a mistake when he filled in the report of patient. The adverse event reproted as life threatening should be changed to that he required emergency room doctor visit.
12 hours later: fever, fatigue, chills, body aches, headache. Still experiencing ( has been less than 24 hours)
Forgot to dilute the pediatric Pfizer vial and administered  0.2 cc .
Fluzone HD was administered to a patient who is 57 years old (instead of Flublok or Fluzone quadrivalent); administered on 09/28/23 and was identified on 09/30/23.  no adverse effects were reported by patient
right after vaccine was given i got a head to toe hot flush. i thought it was just anxiety. within 2 minutes i had expolsive diarrhea, felt dizzy. looked in the mirror and saw my neck and chest covered in red rash and hives. felt hot flush again. dr came in noticed hives all over both my arms as well. felt sob and if someone was holding my neck with their hand. given benadryl and epi taken to local er.
petechiae 24x4cm area coverning brachial radialis from below elbow to back of hand on lt forearm; numbness of lt hand;
Redness; Tingling; Itching; This spontaneous case was reported by a physician and describes the occurrence of ERYTHEMA (Redness), PARAESTHESIA (Tingling) and PRURITUS (Itching) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced ERYTHEMA (Redness), PARAESTHESIA (Tingling) and PRURITUS (Itching). At the time of the report, ERYTHEMA (Redness), PARAESTHESIA (Tingling) and PRURITUS (Itching) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medication was reported.  Treatment information was not provided.
Pt recvd vax & following vax exp burning & thightness in the throat, difficulty breathing, asthmatic bronchitis; pt was seen by MD & treated w/steroids & antihistamines; sx have not subsided;
Red, raised, bumps on back between shoulder blades approximately 10 tall and 10 winches wide. also on chest over sternum approx 4 inches by 5 inches. Treated with hydrocortisone cream twice daily for 5 days. Rash bumps formed scabs and that healed almost completely in 7 days.
Unreconstituted Rotarix diluent only; Unreconstituted Rotarix diluent only; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 4-month-old female patient who received Rota (Rotarix lyophilized formulation) (batch number 7H9CH, expiry date 8th July 2023) for prophylaxis.   Co-suspect products included rotavirus vaccine oral applicator device (Rotarix Oral Applicator Device) oral applicator for prophylaxis.   On 7th October 2022, the patient received Rotarix lyophilized formulation and Rotarix Oral Applicator Device. On 7th October 2022, unknown after receiving Rotarix lyophilized formulation and Rotarix Oral Applicator Device, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 10-OCT-2022 Reporter's Comment: The reporter was a office manager. The reporter reported that the patient received unreconstituted Rotarix vaccines diluent portion only. No symptoms reported. The reporter consented to follow up.  Additional supportive information: The reporter gave by error Rotarix diluent portion only ,which led to inappropriate preparation of medication and inappropriate dose of vaccine administered
For the initial vaccination I had head swelling and migraines and for the booster shot, mild head swelling and colitis flare
This spontaneous report was received from a healthcare worker refers to male patient of approximately 1 year old. No information on concurrent conditions and medical history was reported. On 23-JUN-2015 the patient was vaccinated with improperly stored M-M-R II (unknown strength, route and dose) lot # K0071707 with an expiry date of 16-MAY-2016, stored at improperly temperature (51.6 degrees). Concomitant medications were not reported. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
light headed 11 minutes after shoot, sore arm rest of the day. Next day work up really early with muscle aches, fatigue and bad headache. As the day went on got stomach problems
Pinched feeling in shoulder with occasional cold sensation in left arm (not cold to the touch, cold sensation only). Has persisted for a week thus far. Also petechiae on both left and right scapula.
Hot at injection site/warm at injection site; Itchy at injection site; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot at injection site/warm at injection site), VACCINATION SITE PRURITUS (Itchy at injection site) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Hot at injection site/warm at injection site), VACCINATION SITE PRURITUS (Itchy at injection site) and PYREXIA (Fever). At the time of the report, VACCINATION SITE WARMTH (Hot at injection site/warm at injection site), VACCINATION SITE PRURITUS (Itchy at injection site) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.
When the 2nd Covid shot was given to me, it was extremely painful (more painful than any vaccine or injection I have ever received). My arm was sore for the next two weeks and rather than get better, it's gotten progressively worse. I have pain in my shoulder when I hold my arm out and/or hold my arm up. I cannot hold my arm up over my head without pain.  It is so painful at night that it wakes me up at least two or three times a night. I also have pain in my arm when driving. I made an appointment with an Orthopedist (name is given in this report) and his office took an x-ray which showed no arthritis or issue that might cause my pain. He gave me a prescription to go to physical therapy for "shoulder impingement".
2 inch redness and warmth on left arm where vaccine was administered headache, chills, body aches  Tylenol 500mg 2 tablets as needed
Patient became crabby and possibly had a fever earlier in the day, perhaps 4pm however later in the day, around 10 PM, he seemed to have shallow breathing, heart racing, difficulty sleeping, hives all over and a fever.  Almost took him to the ER.  Around midnight I was able to settle him down with nursing, skin to skin contact.
a disconnect/confusion in communicating thoughts to verbal communications or written communications; initial imbalance; flush face; dizzy/unsteady; diarrhea; lethargic; swollen lymph nodes/glands in neck; nausea; headache; body aches; chills; joint pain; fever; exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of COMMUNICATION DISORDER (a disconnect/confusion in communicating thoughts to verbal communications or written communications), BALANCE DISORDER (initial imbalance), FLUSHING (flush face), DIZZINESS (dizzy/unsteady) and DIARRHOEA (diarrhea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COMMUNICATION DISORDER (a disconnect/confusion in communicating thoughts to verbal communications or written communications), BALANCE DISORDER (initial imbalance), FLUSHING (flush face), DIZZINESS (dizzy/unsteady), DIARRHOEA (diarrhea), LETHARGY (lethargic), LYMPHADENITIS (swollen lymph nodes/glands in neck), NAUSEA (nausea), HEADACHE (headache), MYALGIA (body aches), CHILLS (chills), ARTHRALGIA (joint pain), PYREXIA (fever) and FATIGUE (exhaustion). At the time of the report, COMMUNICATION DISORDER (a disconnect/confusion in communicating thoughts to verbal communications or written communications), BALANCE DISORDER (initial imbalance), FLUSHING (flush face), DIZZINESS (dizzy/unsteady), DIARRHOEA (diarrhea), LETHARGY (lethargic), LYMPHADENITIS (swollen lymph nodes/glands in neck), NAUSEA (nausea), HEADACHE (headache), MYALGIA (body aches), CHILLS (chills), ARTHRALGIA (joint pain), PYREXIA (fever) and FATIGUE (exhaustion) outcome was unknown.            No concomitant medications were provided No treatment medications were provided
Information has been received from a physician concerning a 12 year old female with no illness at the time of vaccination who on 08-DEC-2006 was vaccinated with a 0.5 ml first dose of Gardasil (yeast) (lot 653938/0954F). On 08-DEC-2006, the patient was concomitantly vaccinated with a first dose of Menatra, a dose of influenza virus vaccine (unspecified) and a dose of Boostrix. On 08-Dec-2006, the patient fainted shortly after vaccination. She fell from a standing position and hit the back of head on the floor. She was unconscious for approximately 30 seconds,a and then was dazed and pale. The patient was "ok" after a few minutes. The patient complained of a headache, frontal to occipital. The patient was "ok" at home later that evening. The patient recovered with no sequalae on 08-DEC-2006. Additional information is not expected.
Breakthrough case admission after 4 vaccines Moderna 2/28/21 lot# 010A21A;  mOdern a3/28/21 Lot# 018B21A ; MOdern a12/29/21 lot# 041J21A;  Moderna 6/29/22 lot# 060A22A
rash on stomach, hand, face and neck; This is a spontaneous report from a contactable consumer (patient). A 16-year-old male patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, Lot Number: Ew0171), via an unspecified route of administration, administered in the left arm on 12May2021 at 17:15 as a single dose for COVID-19 immunization. The patient had no medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medication within 2 weeks of vaccination. Since the vaccination, the patient has not been tested for COVID-19. On 21May2021, the patient developed rash on stomach, hand, face and neck. The patient received Benadryl and cortizone-10 as treatment for the event. The outcome of the event was not recovered. The event was reported as non-serious.
First I noticed some red spots on my left thigh and then the next morning when I got up they had spread. Which happened on a Tuesday night and Wednesday morning I called the doctor but I couldn't get in that day so I got an appointment for that Thursday. Every day they were spreading more on my inner and outer left thigh and my left buttock. They didn't go above my waist and they just stayed on my lower left thigh but didn't go up to my stomach and I didn't have any on my stomach.  My doctor told me it was shingles.
Swollen at the injection site, hard lump the size of half a golf ball, warmness, fever, headache, chills, and backache
Lymph node under right armpit swelled up to approximately the size of a golf ball 1 - ½ days after vaccination. No treatment. It subsided within 2 weeks. Also had sore arm, headache (not unusual for me) and mild chills within approximately 24 hours of vaccination. Took Excedrin for those symptoms, which subsided within a day or so.
Patient experienced three episodes of syncope between 1000-1100 on Sunday, 2/28 after receiving the vaccine on Saturday, 2/27 at approximately 1810.  Loss of responsiveness ranged from approximately three to twenty seconds.  Two of the three episodes were witnessed.  Episode one occurred when patient attempted to sit up after waking.   Episodes two and three occurred while attempting to change position from sitting to standing.  Episodes were preceded by flushing, diaphoresis, graying/blackening vision, and tremulousness.  Patient had not experienced syncope prior to these events.  Patient recovered at home with increased fluids and rest on Sunday, 2/28 and outpatient infusion of normal saline at a naturopathic clinic on Monday, 3/1.  Patient experience no further episodes of syncope as of 3/8 but did have multiple episodes of near-syncope in the week following vaccination.   Syncope started at approximately 10 am on Sunday after having received the vaccine on Saturday at approximately 6:10 pm.
This is an instance of breakthrough COVID-19 disease after which death occurred. The adverse event also occurred 5 days after receipt of the third vaccine dose.   The individual was vaccinated with the Moderna product on 02/10/2021, 03/11/2021 and 11/03/2021. The third dose was administered at a different facility than the first two, at Clinic. The individual tested positive for COVID-19 on 11/08/2021 and died later on the same day. Death certificate lists Myocardial Infarction, Congestive Heart Failure, Chronic Disatolic Congestive Heart Failure, and Previous Stroke as causes of death. Other significant conditions listed are hyperlipidemia, hypertension, coronary artery disease, and COVID-19 positive.